Maryland patients, particularly those living with chronic health conditions, need consistent access to medications that manage symptoms and enable them to live healthy and fulfilling lives. Patients often have to navigate a complicated health system where multiple health system middlemen impact that access, and what patients pay at the pharmacy.
As the Maryland Prescription Drug Affordability Board (PDAB) examines high medication costs across the health system, board members must ensure that Maryland patients are ultimately the ones benefiting from any efforts to lower health care costs and realized savings.
